Q BioMed Announces 2nd Closing on Funding and Advances Cancer Palliation Drug

COMPANY GEARS UP FOR PRODUCTION OF CANCER PAIN PALLIATION DRUG WITH COMMERCIAL LAUNCH EXPECTED IN Q2 2017   NEW YORK, March 22, 2017 — Q BioMed Inc. (OTCQB: QBIO), has closed on its 2nd tranche of the $4,000,000 funding announced on November 30th 2016. The company received $1,000,000 on the 2nd closing bringing the total […]

Read More
Social media & sharing icons powered by UltimatelySocial